Analisis Keuangan Saham GRTS - Gritstone bio, Inc. (NasdaqGS) Stock

Gambaran Umum

Ang Gritstone bio, Inc., na nakabase sa United States, ay pangunahing gumagana sa industriya ng biotechnology, na nakatuon sa pagbuo ng mga personalized na immunotherapies at bakuna sa kanser. Isang pangunahing manlalaro sa oncology at mga nakakahawang sakit na sektor, ginagamit ng kumpanya ang proprietary EDGE™ (Epitope Discovery in cancer GEnomes) machine learning platform nito para matukoy ang mga target na partikular sa tumor at gumawa ng mga indibidwal na neoantigen immunotherapies. Sinisiyasat din ng Gritstone Bio ang nakakahawang sakit na tanawin, gaya ng ipinakita ng pagbuo nito ng isang pangalawang henerasyong bakuna sa COVID-19, na idinisenyo upang magbigay ng malawak na proteksyon laban sa maraming mga strain ng coronavirus. Ang makabagong diskarte ng kumpanya ay naglalayong lubos na isulong ang bisa ng mga paggamot para sa parehong kanser at mga nakakahawang sakit, na iposisyon ito sa unahan ng naka-target na therapy at pagbuo ng bakuna.

Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)

Laporan Laba Rugi: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted

Arus Kas: Operasi, Investasi, Pendanaan

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)

Metrik Penilaian: PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV

Metrik Penilaian: EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV

Efektivitas Manajemen

Period End (TTM)	ROA	ROE	ROIC (Tingkat Pengembalian Investasi Modal)	CROIC	OCROIC

Gross Margins

Margin Kotor: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Margin Keuntungan Bersih: Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.

Margin Operasi: Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.

Period End (TTM)	Margin Kotor	Margin Keuntungan Bersih	Margin Operasi